Return to Listing

2 result(s) for stivarga

PI Name Protocol # Title
Lara Davis IRB00010529 SARC024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing–like sarcomas
Gina Vaccaro IRB00010759 A Randomized, Double-Blind Study of Ruxolitinib or Placebo in Combination with Regorafenib in Subjects with Relapsed or Refractory Metastatic Colorectal Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080